About 19,100,000 results
  1. Newsroom - Pfizer

  2. Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance

  3. Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …

  4. Pfizer rolls out another cost-cutting program, sets $1.5 billion …

  5. Press Releases - Pfizer

  6. FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …

  7. CDC identifies possible safety issue with Pfizer’s updated ... - CNN

  8. The FDA just approved the new Covid vaccine: When to get it ... - NBC News

  9. FDA Approves Pfizer Vaccine: Live Updates - The New York Times

  10. Pfizer pins hopes on record pipeline to recover from post-Covid …

  11. Pfizer’s gene therapy for rare genetic bleeding disorder ... - CNBC

  12. FDA Approves First COVID-19 Vaccine

  13. Pfizer : Phase 2 Study Of Ponsegromab In Cancer ... - Markets …

  14. Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …

  15. Why Pfizer's FDA Approval Matters And What It Means For …

  16. Pfizer, Inc. Common Stock (PFE) Stock Price, Quote, News & History - Nasdaq

  17. FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …

  18. Beyond The Numbers: 13 Analysts Discuss Pfizer Stock

  19. Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.

  20. ESMO 2024: Pfizer’s cachexia drug provides meaningful weight gain

  21. Pfizer and BioNTech Announce Vaccine Candidate Against COVID …

  22. Readout Newsletter: Keytruda, IRA, Pfizer, psychedelics - STAT

  23. INTC, MSFT, META, PFE, TSLA: Top Trending Stocks Today - Benzinga

  24. Fawn Creek township, Montgomery County, Kansas (KS) detailed …

  25. Kansas Governor Kelly signs ‘sanctuary city’ bill, dealing harsh blow ...

  26. Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …

  27. Year-long bridge replacement project set to impact Marshall Co ... - WIBW

  28. Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 …

  29. Kansas immigrants say they face 'unsafe and ... - NPR in Kansas City

  30. Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically …

  31. Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab …

  32. Some results have been removed